These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6193229)
1. Selective suppression of an early step in human B cell activation by cyclosporin A. Muraguchi A; Butler JL; Kehrl JH; Falkoff RJ; Fauci AS J Exp Med; 1983 Sep; 158(3):690-702. PubMed ID: 6193229 [TBL] [Abstract][Full Text] [Related]
2. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Kehrl JH; Muraguchi A; Fauci AS Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210 [TBL] [Abstract][Full Text] [Related]
3. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process. Bowen DL; Fauci AS J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141 [TBL] [Abstract][Full Text] [Related]
4. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. Muraguchi A; Kehrl JH; Butler JL; Fauci AS J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443 [TBL] [Abstract][Full Text] [Related]
5. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria. Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163 [TBL] [Abstract][Full Text] [Related]
6. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system. Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616 [TBL] [Abstract][Full Text] [Related]
7. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor. Kehrl JH; Grove JH; Goldsmith PK; Fauci AS Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645 [TBL] [Abstract][Full Text] [Related]
8. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
9. The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells. Kehrl JH; Muraguchi A; Goldsmith PK; Fauci AS Cell Immunol; 1985 Nov; 96(1):38-48. PubMed ID: 2424621 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754 [TBL] [Abstract][Full Text] [Related]
11. Activation and immunoregulation of human B lymphocytes. Kehrl JH; Muraguchi A; Falkoff RJ; Ambrus JL; Butler JL; Fauci AS Uremia Invest; 1984-1985; 8(3-4):157-66. PubMed ID: 6085841 [TBL] [Abstract][Full Text] [Related]
12. The effects of interleukin 1 on human B cell activation and proliferation. Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A directly inhibits human B-cell proliferation by more than a single mechanism. Hannam-Harris AC; Taylor DS; Nowell PC J Leukoc Biol; 1985 Aug; 38(2):231-9. PubMed ID: 3875675 [TBL] [Abstract][Full Text] [Related]
14. T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice. Pure E; Isakson PC; Kappler JW; Marrack P; Krammer PH; Vitetta ES J Exp Med; 1983 Feb; 157(2):600-12. PubMed ID: 6600488 [TBL] [Abstract][Full Text] [Related]
15. Effects of diacetyl diamines on in vitro activation and proliferation of human B lymphocytes. Lacy J; Summers WC; Canellakis ZN J Immunol; 1985 Dec; 135(6):3772-6. PubMed ID: 3877754 [TBL] [Abstract][Full Text] [Related]
16. Abnormal production of and response to B-cell growth factor and B-cell differentiation factor in patients with systemic lupus erythematosus. Hirose T; Hara M; Kitani A; Hirose W; Norioka K; Kawagoe M; Nakamura H Scand J Immunol; 1985 Feb; 21(2):141-50. PubMed ID: 3871963 [TBL] [Abstract][Full Text] [Related]
18. B cell growth-promoting activity of recombinant human interleukin 4. Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
20. Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I). Hirano T; Teranishi T; Onoue K J Immunol; 1984 Jan; 132(1):229-34. PubMed ID: 6228579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]